Login / Signup

Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease.

Catharina C MoorJudith C OppenheimerGizal NakshbandiJoachim G J V AertsPaul BrinkmanAnke-Hilse Maitland-van der ZeeMarlies S Wijsenbeek
Published in: The European respiratory journal (2021)
eNose technology can completely distinguish ILD patients from healthy controls and can accurately discriminate between different ILD subgroups. Hence, exhaled breath analysis using eNose technology could be a novel biomarker in ILD, enabling timely diagnosis in the future.
Keyphrases
  • interstitial lung disease
  • systemic sclerosis
  • rheumatoid arthritis
  • idiopathic pulmonary fibrosis
  • end stage renal disease
  • ejection fraction
  • peritoneal dialysis
  • current status
  • patient reported outcomes